DK314387A - Oralt ketotifenpraeparat - Google Patents

Oralt ketotifenpraeparat

Info

Publication number
DK314387A
DK314387A DK314387A DK314387A DK314387A DK 314387 A DK314387 A DK 314387A DK 314387 A DK314387 A DK 314387A DK 314387 A DK314387 A DK 314387A DK 314387 A DK314387 A DK 314387A
Authority
DK
Denmark
Prior art keywords
ketotifence
oral
preparation
oral ketotifence
ketotifence preparation
Prior art date
Application number
DK314387A
Other languages
Danish (da)
English (en)
Other versions
DK314387D0 (da
Inventor
Hansruedi Surer
Aldo Riva
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of DK314387D0 publication Critical patent/DK314387D0/da
Publication of DK314387A publication Critical patent/DK314387A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
DK314387A 1986-06-21 1987-06-19 Oralt ketotifenpraeparat DK314387A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3620830 1986-06-21

Publications (2)

Publication Number Publication Date
DK314387D0 DK314387D0 (da) 1987-06-19
DK314387A true DK314387A (da) 1987-12-22

Family

ID=6303418

Family Applications (1)

Application Number Title Priority Date Filing Date
DK314387A DK314387A (da) 1986-06-21 1987-06-19 Oralt ketotifenpraeparat

Country Status (30)

Country Link
US (1) US5399360A (xx)
JP (2) JPS638332A (xx)
KR (1) KR880000095A (xx)
AT (1) AT400521B (xx)
AU (1) AU611637B2 (xx)
BE (1) BE1000661A4 (xx)
CA (1) CA1314227C (xx)
CH (3) CH672735A5 (xx)
CY (1) CY1589A (xx)
DE (1) DE3719818C2 (xx)
DK (1) DK314387A (xx)
ES (1) ES2006170A6 (xx)
FI (1) FI872733A (xx)
FR (1) FR2600253B1 (xx)
GB (1) GB2191696B (xx)
GR (1) GR870965B (xx)
HK (1) HK27691A (xx)
HU (1) HU202753B (xx)
IE (1) IE59178B1 (xx)
IL (1) IL82924A (xx)
IT (1) IT1216822B (xx)
LU (1) LU86928A1 (xx)
MY (1) MY101566A (xx)
NL (1) NL8701335A (xx)
NO (1) NO872551L (xx)
NZ (1) NZ220769A (xx)
PH (1) PH26313A (xx)
PT (1) PT85128B (xx)
SE (1) SE8702563L (xx)
ZA (1) ZA874450B (xx)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5891460A (en) * 1995-06-07 1999-04-06 University Of Southern California University Park Campus Method for reducing or preventing post-surgical adhesion formation using ketotifen and analogs thereof
AU7833698A (en) 1997-06-09 1998-12-30 Bridge Pharma, Inc. Compounds with combined antihistaminic and mast cell stabilizing activities, intended for ophthalmic use
US6740889B1 (en) * 1998-09-28 2004-05-25 Applied Materials, Inc. Charged particle beam microscope with minicolumn
AU5139800A (en) * 1999-12-01 2001-06-12 Klein Pharmaceuticals Topical administration of ketotifen
US20030153620A1 (en) * 2000-05-12 2003-08-14 Meakin Timothy David Treating eczema and/or psoriasis
NZ514536A (en) * 2001-09-28 2005-02-25 Meracol Corp Ltd Use of cetyl myristate and/or cetyl palmitate to treat asthma, chronic obstructive pulmonary disease and/or other respiratory difficulties
ITMI20012366A1 (it) * 2001-11-09 2003-05-09 Farmatron Ltd Sistemi terapeutici stabilizzati a rilascio immediato e/o modificato per la somministrazione orale di principi attivi e/o eccipienti e/o ali
JP4867128B2 (ja) * 2002-10-01 2012-02-01 大正製薬株式会社 経口鼻炎治療用組成物
US20060280789A1 (en) * 2004-12-27 2006-12-14 Eisai Research Institute Sustained release formulations
US20090208579A1 (en) * 2004-12-27 2009-08-20 Eisai R & D Management Co., Ltd. Matrix Type Sustained-Release Preparation Containing Basic Drug or Salt Thereof, and Method for Manufacturing the Same
US20060246003A1 (en) * 2004-12-27 2006-11-02 Eisai Co. Ltd. Composition containing anti-dementia drug
JP2008525313A (ja) * 2004-12-27 2008-07-17 エーザイ・アール・アンド・ディー・マネジメント株式会社 抗痴呆薬の安定化方法
US20070129402A1 (en) * 2004-12-27 2007-06-07 Eisai Research Institute Sustained release formulations
US20060160852A1 (en) * 2004-12-27 2006-07-20 Eisai Co. Ltd. Composition containing anti-dementia drug
US20060159753A1 (en) * 2004-12-27 2006-07-20 Eisai Co. Ltd. Matrix type sustained-release preparation containing basic drug or salt thereof
WO2008153761A1 (en) * 2007-05-23 2008-12-18 Mastcell Pharmaceuticals, Inc. Methods
WO2009142772A2 (en) * 2008-05-23 2009-11-26 Mastcell Pharmaceuticals, Inc. Methods and treatment for allergies and inflammation associated with gastrointestinal diseases
EP2589378A1 (en) * 2010-10-14 2013-05-08 Deva Holding Anonim Sirketi Coating of cetyl myristate and/or cetyl palmitate particles

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH531000A (de) * 1970-03-11 1972-11-30 Sandoz Ag Verfahren zur Herstellung neuer Benzocycloheptathiophene
DE2360796B2 (de) * 1973-12-06 1977-06-02 Edelfettwerke Werner Schlüter, 2000 Hamburg; Glyco Iberica S.A., Gava, Barcelona (Spanien) Vti: Hegel, K.Th., Dr.; Dickel, K., Dipl.-Ing.; Pat.-Anwälte, 2000 Hamburg und 8000 München Arzneimittel mit verzoegerter abgabe des wirkstoffs im darm
DE2426811A1 (de) * 1974-06-04 1976-01-08 Klinge Co Chem Pharm Fab Verfahren zur herstellung von retard-tabletten
JPS51142543A (en) * 1975-05-20 1976-12-08 Sandoz Ag Improvement in organic compound
US4073915A (en) * 1975-05-20 1978-02-14 Sandoz Ltd. Treating asthma
FR2440371A1 (fr) * 1978-10-31 1980-05-30 Fisons Ltd Nouveaux composes azotes heterocycliques, des compositions pharmaceutiques en contenant et des procedes pour les preparer
GB2154874B (en) * 1984-02-29 1987-11-04 Sandoz Ltd Bromoscriptine compositions
JPH0667835B2 (ja) * 1984-03-01 1994-08-31 サンド・アクチエンゲゼルシヤフト 医薬組成物
DE3421468A1 (de) * 1984-06-08 1985-12-19 Dr. Rentschler Arzneimittel Gmbh & Co, 7958 Laupheim Lipidnanopellets als traegersystem fuer arzneimittel zur peroralen anwendung
IT1200102B (it) * 1984-08-16 1989-01-05 Sandoz Ag Preparazioni farmaceutiche comprendenti chetotifere ed una xartina ad azione antiasmatica in combinazione fissa
US5069911A (en) * 1985-02-05 1991-12-03 Sandoz Ltd. Pharmaceutical 9,10-dihydrogenated ergot alkaloid containing compositions
DE3505433A1 (de) * 1985-02-16 1986-08-21 Basf Ag, 6700 Ludwigshafen Direkttablettierhilfsmittel
FR2581541B1 (fr) * 1985-05-09 1988-05-20 Rhone Poulenc Sante Nouvelles compositions pharmaceutiques permettant la liberation prolongee d'un principe actif et leur procede de preparation
US4797286A (en) * 1985-11-12 1989-01-10 Eli Lilly And Company Orally administerable sustained release pharmaceutical formulations
US4798725A (en) * 1986-06-16 1989-01-17 Norwich Eaton Pharmaceuticals, Inc. Sustained release capsule

Also Published As

Publication number Publication date
GB2191696B (en) 1991-01-16
FI872733A0 (fi) 1987-06-18
JPS638332A (ja) 1988-01-14
NL8701335A (nl) 1988-01-18
IL82924A0 (en) 1987-12-20
DE3719818C2 (de) 1997-02-13
IT1216822B (it) 1990-03-14
FR2600253A1 (fr) 1987-12-24
NO872551L (no) 1987-12-22
DK314387D0 (da) 1987-06-19
IT8748075A0 (it) 1987-06-19
DE3719818A1 (de) 1987-12-23
JPH05246849A (ja) 1993-09-24
NO872551D0 (no) 1987-06-18
CH674805A5 (xx) 1990-07-31
CH672735A5 (xx) 1989-12-29
IE59178B1 (en) 1994-01-26
PH26313A (en) 1992-04-23
HUT47428A (en) 1989-03-28
HK27691A (en) 1991-04-19
CH676201A5 (xx) 1990-12-28
PT85128B (pt) 1990-03-30
GB8714131D0 (en) 1987-07-22
ZA874450B (en) 1989-01-25
AT400521B (de) 1996-01-25
AU611637B2 (en) 1991-06-20
CY1589A (en) 1992-04-03
IL82924A (en) 1992-11-15
ES2006170A6 (es) 1989-04-16
LU86928A1 (fr) 1988-01-20
US5399360A (en) 1995-03-21
NZ220769A (en) 1990-12-21
IE871634L (en) 1987-12-21
SE8702563D0 (sv) 1987-06-18
AU7452587A (en) 1987-12-24
FR2600253B1 (fr) 1990-01-26
BE1000661A4 (fr) 1989-03-07
GB2191696A (en) 1987-12-23
CA1314227C (en) 1993-03-09
HU202753B (en) 1991-04-29
ATA156187A (de) 1995-06-15
KR880000095A (ko) 1988-03-23
PT85128A (en) 1987-07-01
FI872733A (fi) 1987-12-22
GR870965B (en) 1987-10-20
SE8702563L (sv) 1987-12-22
MY101566A (en) 1991-12-17
JP2860013B2 (ja) 1999-02-24

Similar Documents

Publication Publication Date Title
DK130287D0 (da) Oralt praeparat
DK60885A (da) Oralt praeparat
DK184788D0 (da) Cytotoxisk praeparat
DK686187D0 (da) Veterinaert praeparat
NO172325C (no) Munnpreparat
DK314387A (da) Oralt ketotifenpraeparat
BR8701463A (pt) Composicao oral antiplaca
DK10087D0 (da) Praeparat
AT386518B (de) Zahnersatz
DK244488A (da) Efterskummende praeparat
DK255787D0 (da) Praeparat
AT384729B (de) Artikulator
DK8188D0 (da) Veterinaert praeparat
DK30788D0 (da) Co-vaccinationspraeparat
DK662587A (da) Herbicidt praeparat
NO172275C (no) Oralt antitannstenpreparat
ATA88686A (de) Artikulator
DK523186D0 (da) Praeparat
DK662987D0 (da) Virucidt praeparat
SE8601715D0 (sv) Spanplattor beranordning
DK604286D0 (da) Praeparat
DK552286D0 (da) Tandbaerste
NO872843L (no) Desensitiverende dentalpreparat.
RO94155A2 (ro) Gel oral
SE8602975D0 (sv) Farmaceutisk beredning

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment